News & Press

News & Press 2019-05-08T10:29:55+00:00

News

Swedish Dental and Pharmaceutical Benefits Agency (TLV) authorizes reimbursement of Lecigon®

Parkinson News Today April 2019
Read more

Nordic Life Science April 2019
Read more

Life Science Sweden April 2019
Read more

Neurologi i Sverige April 2019
Read more

Lobsor granted US patent for new levodopa replacement formulation

Press Release 20 March 2019

Biospace March 2019
Read more

Nordic Life Science March 2019
Read more

Swedish Startup Mulls Listing in AbbVie Parkinson’s Challenge

Bloomberg Oct 2018
Read more

Nytt hopp för Parkinsondrabbade (Swedish)

Medicinsk Access nov 2017
Read more

Recipharm tecknar avtal med LobSor Pharmaceuticals (Swedish)

Recifarm
Read more

Primary Endpoint achieved in pivotal EU study

Businesswire
Read more

Lecigon now launched in Sweden

First patient to be treated in May 2019
Read more

Roger Bolsöy


Ulf Rosen
Chairman, Lobsor Holding AB
Download for better resolution

Ulf Rosén


Roger Bolsöy
CEO, Lobsor Pharmaceuticals AB
Download for better resolution

 

Welcome to Lobsor Pharmaceuticals

The product information presented on this website is intended for healthcare professionals only. By clicking “I accept” you will be presented with the information.

Lecigon® is currently approved in Sweden.